0.7481
price down icon3.94%   -0.0307
after-market After Hours: .73 -0.0181 -2.42%
loading
Immunic Inc stock is traded at $0.7481, with a volume of 2.24M. It is down -3.94% in the last 24 hours and down -23.53% over the past month. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
See More
Previous Close:
$0.7788
Open:
$0.7849
24h Volume:
2.24M
Relative Volume:
1.64
Market Cap:
$73.80M
Revenue:
-
Net Income/Loss:
$-93.61M
P/E Ratio:
-0.3545
EPS:
-2.11
Net Cash Flow:
$-71.16M
1W Performance:
-10.41%
1M Performance:
-23.53%
6M Performance:
-34.95%
1Y Performance:
-37.13%
1-Day Range:
Value
$0.7262
$0.7854
1-Week Range:
Value
$0.7262
$0.8699
52-Week Range:
Value
$0.561
$1.42

Immunic Inc Stock (IMUX) Company Profile

Name
Name
Immunic Inc
Name
Phone
(332) 255-9818
Name
Address
1200 AVENUE OF THE AMERICAS, NEW YORK
Name
Employee
90
Name
Twitter
@ImmunicInc
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
IMUX's Discussions on Twitter

Compare IMUX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IMUX
Immunic Inc
0.7481 76.83M 0 -93.61M -71.16M -2.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Immunic Inc Stock (IMUX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-29-25 Initiated Chardan Capital Markets Buy
Mar-25-25 Initiated William Blair Outperform
Nov-25-24 Initiated H.C. Wainwright Buy
Sep-09-24 Resumed Leerink Partners Outperform
Aug-27-24 Initiated B. Riley Securities Buy
Oct-21-22 Downgrade SVB Leerink Outperform → Mkt Perform
Sep-19-22 Resumed H.C. Wainwright Buy
Apr-15-21 Initiated Aegis Capital Buy
Mar-24-21 Initiated JMP Securities Mkt Outperform
Oct-02-20 Initiated SVB Leerink Outperform
Aug-26-20 Initiated Piper Sandler Overweight
Aug-07-20 Resumed ROTH Capital Buy
Jul-20-20 Initiated BMO Capital Markets Outperform
Jun-05-20 Initiated Wedbush Outperform
May-11-20 Initiated H.C. Wainwright Buy
Mar-25-20 Initiated ROTH Capital Buy
Jul-11-19 Initiated Chardan Capital Markets Buy
View All

Immunic Inc Stock (IMUX) Latest News

pulisher
Nov 03, 2025

Will Immunic Inc. (10VA) stock outperform global peersSell Signal & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Forecasting Immunic Inc. price range with options data2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Immunic Inc. stock a top momentum playJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Evaluating Immunic Inc. with trendline analysis2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What does recent volatility data suggest for Immunic Inc.2025 Key Lessons & AI Driven Price Predictions - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Immunic Inc. (10VA) stock a momentum leader2025 Earnings Surprises & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Immunic Inc. stock resilient to inflationTrade Signal Summary & Technical Pattern Based Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What high frequency data says about Immunic Inc.July 2025 Levels & Real-Time Stock Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

News impact scoring models applied to Immunic Inc.Volume Spike & Daily Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Will Immunic Inc. stock see PE expansionWall Street Watch & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Immunic Inc. (10VA) stock positioned for secular growthTrade Risk Assessment & Daily Technical Forecast Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Immunic to Participate in Industry and Investor Conferences in November - Sahm

Nov 02, 2025
pulisher
Nov 02, 2025

Immunic (IMUX) Price Target Decreased by 17.29% to 6.41 - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Price momentum metrics for Immunic Inc. explainedJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Immunic, Inc. (IMUX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

What sentiment indicators say about Immunic Inc. stockQuarterly Profit Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Immunic (IMUX) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Why Immunic Inc. (10VA) stock benefits from AI revolutionWeekly Investment Recap & Verified Stock Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Immunic Inc. stock supported by strong fundamentalsWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Immunic Inc. stock attractive for growth ETFs2025 Top Gainers & Fast Moving Stock Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 29, 2025

EQS-News: Immunic to Participate in Industry and Investor Conferences in November - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

EQS-News: Immunic AG: Immunic to Participate in Industry and Investor Conferences in November - FinanzNachrichten.de

Oct 29, 2025
pulisher
Oct 29, 2025

Immunic (NASDAQ: IMUX) to join BIO-Europe Vienna and Jefferies London in November - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

Immunic to participate in BIO-Europe and Jefferies Global Healthcare conferences in November - Proactive financial news

Oct 29, 2025
pulisher
Oct 28, 2025

Will Immunic Inc. stock continue dividend increases2025 EndofYear Setup & Growth Focused Investment Plans - Fundação Cultural do Pará

Oct 28, 2025

Immunic Inc Stock (IMUX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Cap:     |  Volume (24h):